Sidebar

  • Magazine
  • Events
  • Videos
  • Gallery
  • Blog
  • Gantry Home

Magazine menu

  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
The Power of Truth®
Saturday, May 10, 2025
Saturday, May 10, 2025
  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
  1. You are here:  
  2. Health

Study points at novel approach to treat Group 3 medulloblastoma

Details
Staff logo
09 July 2024
Health
  • Previous Article Stem cell-derived therapy shows promise against treatment-resistant liver cancer
  • Next Article Could a dietary fiber supplement offer long-awaited treatment for food allergy sufferers?
A team of researchers has identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma (Gr3-MB) in the developing brain. Gr3-MB is one of the most aggressive forms of brain cancer in children and is associated with metastatic spread and poor survival. The researchers showed that eliminating the small population of stem-like cells present in Gr3-MB tumors led to tumor shrinkage in preclinical models. Although more research is needed, this novel approach may lead to new ways to treat children with Gr3-MB.
A team of researchers has identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma (Gr3-MB) in the developing brain. Gr3-MB is one of the most aggressive forms of brain cancer in children and is associated with metastatic spread and poor survival. The researchers showed that eliminating the small population of stem-like cells present in Gr3-MB tumors led to tumor shrinkage in preclinical models. Although more research is needed, this novel approach may lead to new ways to treat children with Gr3-MB.

Read more https://www.sciencedaily.com/releases/2024/07/240709184222.htm

  • Previous Article Stem cell-derived therapy shows promise against treatment-resistant liver cancer
  • Next Article Could a dietary fiber supplement offer long-awaited treatment for food allergy sufferers?

HUNGRY FOR TRUTH?  FEED THE NEED.

The Power of Truth®
  • Cookies Policy
  • Privacy Policy
  • Terms of Use
  • Contact
Copyright © 2025 Joomla!. All Rights Reserved. Powered by The Power of Truth® - Designed by JoomlArt.com. Bootstrap is a front-end framework of Twitter, Inc. Code licensed under Apache License v2.0. Font Awesome font licensed under SIL OFL 1.1.